VOYA Investment Management
IOVA icon

VOYA Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History

VOYA Investment Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$202K Buy
57,441
+3,964
+7% +$12.7K ﹤0.01% 2115
2025
Q4 		$146K Buy
53,477
+6,300
+13% +$14.6K ﹤0.01% 2205
2025
Q3 		$102K Sell
47,177
-24,575
-34% -$58K ﹤0.01% 2299
2025
Q2 		$123K Sell
71,752
-1,967
-3% -$4.89K ﹤0.01% 2444
2025
Q1 		$245K Sell
73,719
-96,018
-57% -$495K ﹤0.01% 2224
2024
Q4 		$1.26M Sell
169,737
-3,307
-2% -$30.7K ﹤0.01% 1489
2024
Q3 		$1.62M Buy
173,044
+159
+0.1% +$1.51K ﹤0.01% 1410
2024
Q2 		$1.39M Sell
172,885
-27,028
-14% -$290K ﹤0.01% 1455
2024
Q1 		$2.96M Buy
199,913
+38,889
+24% +$453K ﹤0.01% 1186
2023
Q4 		$1.31M Sell
161,024
-278
-0.2% -$1.46K ﹤0.01% 1536
2023
Q3 		$734K Buy
161,302
+9,837
+6% +$64.2K ﹤0.01% 1831
2023
Q2 		$1.07M Sell
151,465
-100,896
-40% -$722K ﹤0.01% 1635
2023
Q1 		$1.54M Buy
252,361
+58,385
+30% +$403K ﹤0.01% 1455
2022
Q4 		$1.24M Hold
193,976
– – ﹤0.01% 1542
2022
Q3 		$1.86M Buy
193,976
+137,261
+242% +$1.58M ﹤0.01% 1348
2022
Q2 		$626K Buy
56,715
+19,926
+54% +$261K ﹤0.01% 1697
2022
Q1 		$613K Sell
36,789
-344
-0.9% -$5.32K ﹤0.01% 1785
2021
Q4 		$709K Buy
37,133
+6,712
+22% +$148K ﹤0.01% 1784
2021
Q3 		$750K Buy
30,421
+72
+0.2% +$1.7K ﹤0.01% 1786
2021
Q2 		$790K Sell
30,349
-15,389
-34% -$400K ﹤0.01% 1806
2021
Q1 		$1.45M Sell
45,738
-2,860
-6% -$119K ﹤0.01% 1353
2020
Q4 		$2.25M Sell
48,598
-286,239
-85% -$11.4M ﹤0.01% 1085
2020
Q3 		$11M Buy
334,837
+38,485
+13% +$1.18M 0.02% 503
2020
Q2 		$8.13M Sell
296,352
-214,390
-42% -$7.05M 0.02% 597
2020
Q1 		$15.3M Sell
510,742
-146,579
-22% -$3.89M 0.04% 364
2019
Q4 		$18.2M Sell
657,321
-356,469
-35% -$8.11M 0.04% 403
2019
Q3 		$18.5M Buy
1,013,790
+497,487
+96% +$11M 0.04% 408
2019
Q2 		$12.7M Buy
516,303
+473,008
+1,093% +$7.12M 0.03% 541
2019
Q1 		$412K Hold
43,295
– – ﹤0.01% 1883
2018
Q4 		$383K Buy
43,295
+10,370
+31% +$100K ﹤0.01% 1885
2018
Q3 		$370K Hold
32,925
– – ﹤0.01% 2024
2018
Q2 		$421K Buy
32,925
+1,635
+5% +$23.9K ﹤0.01% 1927
2018
Q1 		$529K Buy
31,290
+4,883
+18% +$74K ﹤0.01% 1772
2017
Q4 		$211K Sell
26,407
-1,825
-6% -$14.7K ﹤0.01% 2316
2017
Q3 		$219K Hold
28,232
– – ﹤0.01% 2341
2017
Q2 		$208K Buy
28,232
+4,248
+18% +$27K ﹤0.01% 2393
2017
Q1 		$179K Hold
23,984
– – ﹤0.01% 2316
2016
Q4 		$167K Hold
23,984
– – ﹤0.01% 2352
2016
Q3 		$197 Hold
23,984
– – ﹤0.01% 2298
2016
Q2 		$194K Hold
23,984
– – ﹤0.01% 2280
2016
Q1 		$122K Hold
23,984
– – ﹤0.01% 2356
2015
Q4 		$185K Hold
23,984
– – ﹤0.01% 2308
2015
Q3 		$138K Hold
23,984
– – ﹤0.01% 2402
2015
Q2 		$220K Buy
+23,984
New +$268K ﹤0.01% 2435

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

VOYA Investment Management's IOVA Position: Q1 2026 in Review

VOYA Investment Management increased its Iovance Biotherapeutics (IOVA) stake by 7.4% in Q1 2026, buying an estimated $12.7K and bringing the position to 57,441 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

VOYA Investment Management first reported a position in IOVA in Q2 2015 and has held it in 44 quarters since. The position peaked at $18.5M in Q3 2019. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • VOYA Investment Management held 57,441 shares of Iovance Biotherapeutics worth $202K as of Q1 2026.
  • VOYA Investment Management bought 3,964 Iovance Biotherapeutics shares in Q1 2026, an estimated $12.7K.
  • Iovance Biotherapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2115 holding.
  • VOYA Investment Management first reported a position in Iovance Biotherapeutics in Q2 2015 and has held it in 44 quarters since.
  • VOYA Investment Management's Iovance Biotherapeutics position peaked at $18.5M in Q3 2019.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.